Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
2.05
-0.10 (-4.65%)
At close: Aug 15, 2025, 1:24 PM
Connect Biopharma Fail-to-Deliver
Total FTD Shares
5.47K
Below Average
FTD / Avg. Volume
3.46%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Connect Biopharma Limited has
5,467
shares failed to deliver, representing 3.46%
of the average daily volume of
158,154
shares. Over the past year, the monthly average FTD is
6,637
shares, with the current level 18% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 1.41 | 5.47K | +15.22% |
| Jun 30, 2025 | 0.98 | 4.75K | +151.72% |
| May 30, 2025 | 0.84 | 1.89K | -58.73% |
| Apr 29, 2025 | 0.81 | 4.57K | +432.91% |
| Mar 21, 2025 | 0.815 | 857 | +23.49% |
| Feb 27, 2025 | 0.899 | 694 | +1001.59% |
| Jan 17, 2025 | 1.05 | 63 | -98.63% |
| Dec 31, 2024 | 1.38 | 4.59K | -79.11% |
| Nov 29, 2024 | 1.06 | 21.99K | +334.35% |
| Oct 24, 2024 | 1.22 | 5.06K | +5228.42% |
| Sep 30, 2024 | 1.44 | 95 | -92.27% |
| Aug 30, 2024 | 1.6 | 1.23K | -46.12% |
| Jul 30, 2024 | 1.19 | 2.28K | +74.39% |
| Jun 24, 2024 | 1.35 | 1.31K | +363.83% |
| May 31, 2024 | 1.79 | 282 | -55.59% |
| Apr 29, 2024 | 1.37 | 635 | -86.93% |
| Mar 28, 2024 | 1.74 | 4.86K | +142.51% |
| Feb 29, 2024 | 1.18 | 2K | +155.61% |
| Jan 31, 2024 | 1.17 | 784 | -96.28% |
| Dec 28, 2023 | 1.1 | 21.09K | +1657.92% |
| Nov 28, 2023 | 1.02 | 1.2K | -79.26% |
| Oct 26, 2023 | 1.14 | 5.79K | +1131.06% |
| Sep 29, 2023 | 0.819 | 470 | -59.31% |
| Aug 04, 2023 | 0.985 | 1.16K | +913.16% |
| Jul 27, 2023 | 1 | 114 | -99.38% |
| Jun 30, 2023 | 1.13 | 18.27K | +321.77% |
| May 30, 2023 | 1.11 | 4.33K | +143.86% |
| Apr 26, 2023 | 1.04 | 1.78K | -81.63% |
| Mar 31, 2023 | 1 | 9.67K | +22923.81% |
| Feb 28, 2023 | 1.29 | 42 | -99.32% |
| Jan 30, 2023 | 1.23 | 6.2K | n/a |